Rosol Michael Stanley 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Jun 4, 2020
Insider Transaction Report
Form 4
Rosol Michael Stanley
Chief Medical Officer
Transactions
- Award
Common Stock
2020-06-02$2.62/sh+6,847$17,939→ 13,097 total
Footnotes (1)
- [F1]Stock granted under the Amended and Restated 2014 Stock Incentive Plan in lieu of cash bonus.